Becton Dickinson (NYSE:BDX) said today that it launched its BD Neopak 2.25 milliliter prefillable glass syringe designed for high-volume injection of biologics.
The Franklin Lakes, N.J.-based company said that its prefillable glass syringe was developed to reduce drug degradation and aggregation between the container and therapeutic. The high volume syringe is commercially available in the U.S., Europe and Japan.
Get the full story at our sister site, Drug Delivery Business News.
The post BD launches high volume syringe for biologics appeared first on MassDevice.